NEW YORK (GenomeWeb News) - Lumera said today that it has discontinued operations for its Plexera proteomics subsidiary in conjunction with an agreement to merge with GigOptix, a privately held developer of integrated circuits for optical communication systems.
The combined company will be listed on the Nasdaq market under the name GigOptix. GigOptix’s CEO and chairman, Avi Katz, will serve as CEO and chairman of the company following the merger.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers find that historical factors influence which genes are the most highly studied, the Atlantic reports.

The US National Science Foundation's new sexual harassment policy is to go into effect next month, according to Nature News.

Researchers report using genotyping to tie together illegal ivory shipments and trace them back to a handful of cartels, the New York Times reports.

In Nature this week: genomic ancestry analysis of Sardinians, current noncoding mutations in colorectal cancer, and more.